Doug Cole

by s2desi5_ksqtherapeutics | May 20, 2024

Doug Cole joined Flagship Pioneering in 2001. He focuses on life science. At Flagship, Doug has co-founded Ensemble Therapeutics, Foghorn Therapeutics (NASDAQ: FHTX), Inzen Therapeutics, Moderna (NASDAQ: MRNA), Permeon Biologics, Sigilon Therapeutics, (NASDAQ: SGTX),...

Alan Crane, MBA

by s2desi5_ksqtherapeutics | May 20, 2024

Alan Crane is a Partner and Entrepreneur at Polaris Partners focusing on building and investing in healthcare companies. He has served as founder and/or has played a significant role as chairman and CEO in building six Polaris companies including: Momenta...

David Darst

by whicks | Nov 3, 2025

David Darst is a Growth Partner with Flagship Pioneering. David is a board member and co-responsible partner for multiple growth stage portfolio companies. He supports their organizational development, long-term strategy, financing, and business development efforts to...

Kristen Hege, MD

by whicks | Mar 5, 2025

Dr. Hege retired from Bristol Myers Squibb and UCSF in March of 2023 to pursue her lifelong dream of thru hiking the 2650-mile Pacific Crest Trail. In her BMS role as SVP Early Clinical Development, Hematology, Oncology & Cell Therapy, she was responsible for...

Mahesh Karande

by s2desi5_ksqtherapeutics | May 20, 2024

Mahesh is the President and CEO of Omega Therapeutics (Nasdaq: OMGA), a clinical-stage biotechnology company pioneering a new field of epigenomic programming to use mRNA therapeutics as programmable epigenetic medicines. At Omega, he has led the translation of...